Norvasc 10mg 30 tablets — Made in Germany — Free Delivery

- arterial hypertension.

- chronic stable angina pectoris.

- Vasospastic angina (Prinzmetal's angina).

- Hypersensitivity to dihydropyridines, amlodipine or any other component of the preparation.

- severe arterial hypotension.

- Shock (including cardiogenic shock).

- obstruction of the outflow tract of the left ventricle (for example, severe aortic stenosis).

- Hemodynamically unstable heart failure after acute myocardial infarction.

active ingredient: amlodipine besylate; 1 tablet contains 6.944 mg of amlodipine besilate, which is equivalent to 5 mg of amlodipine; 1 tablet contains 13.889 mg of amlodipine besilate, which is equivalent to 10 mg of amlodipine;

Excipients: microcrystalline cellulose, anhydrous calcium hydrogen phosphate, sodium starch (type A), magnesium stearate.

Adults.

For the treatment of arterial hypertension and angina pectoris, the initial dose of Norvasc® is 5 mg 1 time per day. Depending on the patient's response to therapy, the dose may be increased to a maximum dose of 10 mg once daily.

In patients with angina pectoris, the preparation can be used as monotherapy or in combination with other antianginal preparations with nitrate resistance and / or adequate doses of beta-blockers.

There is experience of using the preparation in combination with thiazide diuretics, alpha-blockers, beta-blockers or ACE inhibitors in patients with arterial hypertension.

There is no need to select a dose of the preparation when used simultaneously with thiazide diuretics, beta-blockers and ACE inhibitors.

Children aged 6 years and older with arterial hypertension.

The recommended initial dose of Norvasc® for this category of patients is 2.5 mg once a day. If the desired level of blood pressure is not reached within 4 weeks, the dose can be increased to 5 mg per day. The use of the preparation at a dose of 5 mg for this category of patients has not been studied.

There is no need to select a dose for this category of patients. Increasing the dose should be done with caution.

Patients with impaired renal function.

It is recommended to use the usual doses of the preparation, since changes in the concentration of amlodipine in the blood plasma are not associated with the severity of renal failure. Amlodipine is not excreted by dialysis.